The Oncology Institute, Inc. announced that it has started operations of its first pharmacy in California after receiving approval from the California State Board of Pharmacy. This new service allows TOI to fill not only critical specialty medications and chemotherapeutics for MediCal patients, but also to provide medication fill capabilities to other patient populations. Located in the Los Angeles area, this new pharmacy location comes in addition to the multiple integrated specialty medication dispensaries that TOI already uses to manage oral and injectable medications.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 USD | -3.53% | -13.93% | -73.04% |
May. 14 | Transcript : The Oncology Institute, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Earnings Flash (TOI) TOI MANAGEMENT LLC Reports Q1 Revenue $94.7M, vs. Street Est of $95.2M | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-73.04% | 40.94M | |
+17.74% | 82.59B | |
-29.66% | 69.86B | |
0.00% | 26.5B | |
+3.06% | 17.29B | |
-12.16% | 16.61B | |
+2.47% | 15.56B | |
+74.82% | 13.2B | |
+0.76% | 12.75B | |
+73.52% | 12.6B |
- Stock Market
- Equities
- TOI Stock
- News The Oncology Institute, Inc.
- The Oncology Institute Expands Its Specialty Medication Business by Opening Pharmacy Operations in California